# RapidShock Post-Approval Study

Study · id `cardio:ct-nct04014842` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04014842](<https://clinicaltrials.gov/study/NCT04014842>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04014842

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2756 participants.

## Technical summary

Registry record NCT04014842. Allocation not applicable; no masking; primary purpose treatment. Start 2019-02-26 (actual); primary completion 2023-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2756 participants (enrolled count; ClinicalTrials.gov record NCT04014842, source copy `cardio:ctgov-nct04014842-2024-07-23`, retrieved 2026-10-26)
- Started: 2019-02-26 (actual) (ClinicalTrials.gov record NCT04014842, source copy `cardio:ctgov-nct04014842-2024-07-23`, retrieved 2026-10-26)
- Primary completion: 2023-12-31 (actual) (ClinicalTrials.gov record NCT04014842, source copy `cardio:ctgov-nct04014842-2024-07-23`, retrieved 2026-10-26)
- Completion: 2023-12-31 (actual) (ClinicalTrials.gov record NCT04014842, source copy `cardio:ctgov-nct04014842-2024-07-23`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04014842, source copy `cardio:ctgov-nct04014842-2024-07-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04014842-2024-07-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: RapidShock Post-Approval Study
- Condition: Cardiac Arrest
- Intervention (Device): RapidShock
- Lead sponsor: Zoll Medical Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: Zoll Medical Corporation (`cardio:org-zoll-medical-corporation`)

## Provenance

Content hash: a5babd5bc1d938746eb8e8e58360c39497c9a5b387e7c91af2771a61836edd11
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
